Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients for the Treatment of Severe Aortic Stenosis
Why the study?
Recent randomized trials demonstrated TAVR non-inferiority to SAVR in low surgical risk patients with severe aortic stenosis, paving the way to extend clinical indications.
Does TAVR reduce cardiovascular death compared to SAVR in patients with severe aortic stenosis at low surgical risk?
Population
Nearly 3000 patients with severe aortic stenosis at low surgical risk across three randomized studies
Comparison
TAVR vs SAVR
Design
Meta-analysis of randomized studies
Follow-up
One year
Authors
Discussion
Loading...
Member takes
Implication
Supports expanding TAVR to low-risk severe AS; confirms non-inferiority from pivotal RCTs and strengthens guideline recommendations.
Structured PICO
Does TAVR reduce cardiovascular death compared to SAVR in patients with severe aortic stenosis at low surgical risk?
P
Population
Nearly 3000 patients with severe aortic stenosis at low surgical risk pooled from 3 randomized studies
I
Intervention
Transcatheter aortic valve replacement (TAVR)
C
Comparator
Surgical aortic valve replacement (SAVR)
O
Outcome
Cardiovascular death and all-cause mortality at one yearhard clinical
In low-risk patients with severe aortic stenosis, TAVR reduces cardiovascular death at one year compared to SAVR, but increases the risk of aortic regurgitation and permanent pacemaker implantation.
Cite This Study
Polimeni et al. (2020) studied this question.